Determine the necessary mass, volume, or concentration for preparing a solution.
This is a demo store. No orders will be fulfilled.
| SKU | Size | Availability |
Price | Qty |
|---|---|---|---|---|
|
Ab175614-100μg
|
100μg |
10
|
$59.90
|
|
|
Ab175614-1mg
|
1mg |
4
|
$279.90
|
|
|
Ab175614-5mg
|
5mg |
1
|
$739.90
|
|
|
Ab175614-10mg
|
10mg |
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
|
$1,189.90
|
|
Purity>95% (SDS-PAGE&SEC); Endotoxin Level<1.0EU/mg; Human IgG1; CHO; ELISA, FACS, Functional assay, Animal Model; Unconjugated
| Product Name | Ocrelizumab (anti-CD20) - Primary antibody, specific to MS4A1, >95%, high purity, Human IgG1, Antibody of CD20 (membrane-spanning 4-domains; subfamily A; member 1) |
|---|---|
| Synonyms | APY antibody | ATOPY antibody | B lymphocyte antigen CD20 antibody | B Lymphocyte Cell Surface Antigen B1 antibody | B-lymphocyte antigen CD20 antibody | B-lymphocyte cell-surface antigen B1 antibody | B-lymphocyte surface antigen B1 antibody | B1 antibod |
| Specifications & Purity | Carrier Free, Recombinant, ExactAb™, Low Endotoxin, Azide Free, Validated, Animal Free, ≥95%(SDS-PAGE&SEC-HPLC), See COA |
| Host species | Human |
| Specificity | MS4A1 |
| Conjugation | Unconjugated |
| Grade | Animal Free, Azide Free, Carrier Free, ExactAb™, Low Endotoxin, Recombinant, Validated |
| Action Type | BINDING AGENT |
| Mechanism of action | Antibody of CD20 (membrane-spanning 4-domains; subfamily A; member 1) |
| Product Description |
Ocrelizumab (anti-CD20) is an anti-CD20 antibody that depletes circulating immature and mature B cells but spares CD20-negative plasma cells. The effector mechanisms of Ocrelizumab (anti-CD20) are complement-dependent cytotoxicity and antibody-dependent cellular cytotoxicity. Ocrelizumab (anti-CD20) is the first monoclonal antibody for secondary primary progressive multiple sclerosis (PPMS). |
| Isotype | Human IgG1 |
|---|---|
| Light Chain Type | kappa |
| SDS-PAGE | 145.82 kDa |
| Purification Method | Protein A purified |
| Purity | >95% |
| Shape | Liquid |
| Concentration | See COA |
| Storage Temp | Store at -80°C,Avoid repeated freezing and thawing |
| Shipped In | Ice chest + Ice pads |
| Stability And Storage | Store at -80℃ for 24 months. Upon receipt, it is recommended to aliquot. Avoid freeze/thaw cycle. |
| CAS | 637334-45-3 |
| Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
|---|
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Ocrelizumab (anti-CD20) (Ab175614) - Flow Cytometry
Flow Cytometry analysis of Raji cells labelling CD20 (red) with Ocrelizumab (anti-CD20) (Ab175614). Goat Anti-Human IgG (PE) (Ab175838) at a dilution of 1/1000 was used as the secondary antibody. Blue - Isotype control, human IgG (Ab170213). Black - Unlabelled control, cells without incubation with primary antibody.
Ocrelizumab (anti-CD20) (Ab175614) - SEC
The purity of Ocrelizumab (anti-CD20) (Ab175614) is more than 95% verified by HPLC.
Find and download the COA for your product by matching the lot number on the packaging.
| Lot Number | Certificate Type | Date | Item |
|---|---|---|---|
| Certificate of Analysis | Jan 30, 2024 | Ab175614 | |
| Certificate of Analysis | Jan 30, 2024 | Ab175614 | |
| Certificate of Analysis | Jan 30, 2024 | Ab175614 |
Starting at $109.90
Starting at $199.90
Starting at $51.90
Starting at $119.90
Starting at $96.90
Starting at $59.90
Starting at $49.90
Starting at $46.90
Starting at $109.90
Starting at $29.90
Starting at $151.90
Starting at $25.90
Starting at $39.90
Starting at $109.90
Starting at $147.90
Starting at $109.90